Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04075994 · ClinicalTrials.gov registry record · NA

Atrial Fibrillation Health Literacy and Information Technology Trial

A NA study, sponsored by University of Pittsburgh.

Completed
Registry status
NA
Development phase
243
Enrollment target

NCT04075994 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 243 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04075994, a NA study, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
NA
Development phase
243 participants
Enrollment target

Study Summary

Atrial fibrillation (AF) is a common, morbid condition with increasing prevalence. Poor health-related quality of life is common in AF. Patients experience debilitating symptoms and challenging adherence to long-term (possibly lifelong) anticoagulation. The increased risks of stroke, heart failure and mortality associated with AF persist even with optimal treatment. Morbidity in AF is further exacerbated by social factors. Limited health literacy carries challenges of learning a specialized terminology and navigating specialized treatments. In multiple cardiovascular diseases, self-care has demonstrated improvement in self-efficacy, health-related quality of life, symptom burden, and health care utilization - essential components of patient success with AF. Selfcare can provide the critical skills to navigate a challenging chronic disease and improve patient-centered outcomes. Delivery of self-care as a mobile health intervention can complement standard care with a longitudinal intervention to improve patient-centered strategies for AF. While self-care interventions for AF have focused foremost on self-monitoring of anticoagulation,self-care has demonstrated its potential to meet the "triple aim" of improved patient experience, reduced health care utilization, and lower costs.

Interventions

  • BEHAVIORAL Usual Care
  • BEHAVIORAL Relational Agent and heart rate and rhythm monitor

Trial Details

FieldValue
Enrollment Target 243 participants
Start Date 2020-01-02
Est. Completion 2023-08-01
Phase NA

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT04075994

The ClinicalTrials.gov registry entry for NCT04075994 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 243 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.

NCT04075994 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04075994 about?

NCT04075994 is a clinical study titled "Atrial Fibrillation Health Literacy and Information Technology Trial". Atrial fibrillation (AF) is a common, morbid condition with increasing prevalence. Poor health-related quality of life is common in AF. Patients experience debilitating symptoms and challenging adherence to long-term (possibly lifelong) anticoagulation. The increased risks of stroke, heart failure a...

What is the current status of trial NCT04075994?

This trial is currently completed. It is a NA study. The enrollment target is 243 participants. The study started on 2020-01-02. Estimated completion is 2023-08-01.

What interventions are being tested in trial NCT04075994?

The interventions under investigation include: Usual Care (BEHAVIORAL), Relational Agent and heart rate and rhythm monitor (BEHAVIORAL).

Who is sponsoring clinical trial NCT04075994?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.